Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
12:12p PFIZER : Rise for Pfizer Shares in
10:12a ALLERGAN : Plastic Surgeon Sean Doherty, MD Highlights Safest Approa..
05/03 ALLERGAN : Presents New Data at the American Urological Association ..
SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/08/2012 | 12:11am CEST
   By Anjali Athavaley 
   Of  
 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on ALLERGAN, INC.
12:12p PFIZER : Rise for Pfizer Shares in
10:12a ALLERGAN : Plastic Surgeon Sean Doherty, MD Highlights Safest Approach to Facial..
05/03 ADVANCED VOLUMA® : Santa Monica's Dr. Mark Youssef Employs New Techniques in May
05/03 ALLERGAN : Presents New Data at the American Urological Association Meeting in S..
05/03 PFIZER : tops Street 1Q forecasts on higher sales, lower taxes
05/01 ALLERGAN : Treatment for double chins hits the market this fall
04/30 ALLERGAN : Ora Appoints David Hollander, M.D., M.B.A., as Chief Medical Officer
04/29 ASTRAZENECA : Positive chmp opinion for caz avi
04/29 ALLERGAN : Ora Appoints David Hollander, M.D., M.B.A., As Chief Medical Officer
04/29 ALLERGAN : Acquires Topokine Therapeutics to Focus on Topical Medicines for Unde..
Advertisement
Income Statement Evolution
More Financials